Argent Biopharma (RGTLF)
OTHER OTC:RGTLF
Holding RGTLF?
Track your performance easily

Argent Biopharma (RGTLF) Cash flow

29 Followers

Argent Biopharma Cash Flow

RGTLF's free cash flow for Q4 2022 was AU$―. For the 2022 fiscal year, RGTLF's free cash flow was decreased by AU$-3.42M and operating cash flow was AU$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 24Jun 23Jun 22Jun 21Jun 20
Operating Cash Flow
-AU$ -14.66MAU$ -11.99MAU$ -12.16M--
Investing Cash Flow
-AU$ -140.12KAU$ 606.20KAU$ -1.11MAU$ -1.49MAU$ -969.88K
Financing Cash Flow
-AU$ 15.27MAU$ 9.73MAU$ 9.74MAU$ 17.05MAU$ 10.46M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-AU$ 702.87KAU$ 239.82KAU$ 1.89MAU$ 5.43MAU$ 1.87M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----AU$ 7.40KAU$ 135.58K
Issuance Of Capital Stock
-AU$ 15.94MAU$ 3.09MAU$ 10.70MAU$ 12.76MAU$ 11.43M
Issuance Of Debt
-AU$ -238.68KAU$ 6.96MAU$ -201.58KAU$ 5.75M-
Repayment Of Debt
-AU$ -238.68KAU$ -200.96KAU$ -263.01K--
Free Cash Flow
-AU$ -14.80MAU$ -11.38MAU$ -13.26M-AU$ -10.92M
Domestic Sales
------
Foreign Sales
------
Currency in AUD

Argent Biopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis